Opening Up - SNJ Today snjtoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from snjtoday.com Daily Mail and Mail on Sunday newspapers.
Cancer Liquid Biopsy Developer Bluestar Raises $70M, Adds Venter to Scientific Advisory Board
May 21, 2021
J. Craig Venter, Ph.D.
Bluestar Genomics, the developer of an epigenomic platform focused on early cancer detection, has raised $70 million in an oversubscribed Series C equity financing and named genomics pioneer J. Craig Venter, Ph.D., among two new members of its expanded scientific advisory board.
“Collectively, these milestones will extend our ability to deliver on our promise to improve on existing cancer screening and provide a new solution where none exists,” Samuel Levy, Ph.D., Bluestar’s CEO and Chief Scientific Officer, said in a statement.
Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, today announced the .
Bluestar Genomics Closes $70M Series C Funding, Expands Scientific Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Article content
While ethnic expulsion wasn’t an official declaration in Russia, Poland and Ukraine in the late 1800s, Jewish families were realizing a not-so-subtle push to relieve them of their livelihood. Samuel Levy was a shop keeper who found he had no source of supplies.
Simon Henerofsky, a carpenter, was unable to even buy a new hammer or nails. David Korman, a dairy farmer, was helpless as the Russian soldiers took away his cows, leaving him with no source of income. Isaac Gurevitch lived on the Russian border, witnessed what was happening, so he just walked away from all he owned.